Multiparametric MRI Model Predicts Parenchymal Hematoma in Acute Ischemic Stroke After Reperfusion

Mona Asghariahmadabad1, Lucia Zima1, Ameera Ismail1

  • 1From the Department of Radiology and Biomedical Imaging (M.A., K.N., S.W.H., C.P.H., K.N.), Neurology (N.K., S.A.J.), Neurological Surgery (L.E.S., E.W.), University of California, San Francisco, San Francisco, CA, USA; Department of Radiological Sciences (A.I., K.N.), David Geffen School of Medicine at UCLA, Neurology (M.B.-H., J.L.S., D.S.L.), David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA; Department of Mechanical Engineering (M.K.), University of Washington, Seattle,WA; The Russell H. Morgan Department of Radiology and Radiological Science (V.Y.), Johns Hopkins University School of Medicine, Baltimore, MD, USA and Department of Radiology - CDI (Centre de Diagnòstic per Imatge) (J.P.), Universitat de Barcelona, Barcelona, Spain.

Abstract

Insights

This study shows that baseline MRI diffusion and perfusion imaging can predict parenchymal hematoma (PH) after stroke reperfusion therapy. Quantitative biomarkers accurately identify patients at increased risk for this severe complication.

Area of Science:

  • Neurology
  • Radiology
  • Biomedical Imaging

Background:

  • Parenchymal hematoma (PH) is a serious complication of reperfusion therapy for acute ischemic stroke.
  • PH is linked to poor functional outcomes in stroke patients.

Purpose of the Study:

  • To determine if quantitative imaging biomarkers from baseline MRI can predict PH after reperfusion therapy.
  • To evaluate the utility of diffusion and perfusion MRI metrics in forecasting PH risk.

Main Methods:

  • Retrospective analysis of acute ischemic stroke patients undergoing endovascular thrombectomy.
  • Extraction of quantitative imaging biomarkers: apparent diffusion coefficient (ADC), relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and relative K2 (rK2).
  • Development of a logistic regression model and performance evaluation using ROC analysis and SHAP values.

Main Results:

  • 32 out of 100 patients developed PH.
  • Patients with PH showed lower baseline rCBF, rCBV, and ADC, and higher rK2 values.
  • The predictive model incorporating ADC, rCBF, rCBV, and rK2 achieved 77% accuracy (AUC 0.88).

Conclusions:

  • A quantitative MRI model using ADC, rCBV, rCBF, and rK2 can identify stroke patients at higher risk of PH.
  • This model offers a valuable tool for predicting PH post-reperfusion therapy.
  • The findings highlight the potential of advanced MRI biomarkers in stroke management.